InflaRx (IFRX) Payables (2016 - 2026)

InflaRx has disclosed Payables across 11 years of filings, most recently posting $5.7 million for Q1 2026.

• Payables for Q1 2026 came in at $5.7 million, up 278.1% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.7 million (up 278.1% YoY), and the FY2025 annual result was $6.3 million, down 48.38% from the prior year.
• Payables came in at $5.7 million for Q1 2026 at InflaRx, down from $6.3 million in the prior quarter.
• In the past five years, Payables ranged from a high of $12.2 million in Q4 2024 to a low of -$4.7 million in Q1 2024.
• The 5-year median for Payables is -$279570.4 (2024), against an average of $1.5 million.
• Across the five-year window, Payables tumbled 1690.26% in 2024 and soared 3958.84% in 2025, its largest moves.
• InflaRx's Payables stood at -$3.7 million in 2022, then surged by 305.43% to $7.5 million in 2023, then jumped by 61.97% to $12.2 million in 2024, then tumbled by 48.38% to $6.3 million in 2025, then retreated by 9.75% to $5.7 million in 2026.
• The last three Payables figures came in at $5.7 million (Q1 2026), $6.3 million (Q4 2025), and $10.8 million (Q3 2025), per Business Quant data.